{"id":"https://openalex.org/W13566433","doi":null,"title":"Changes in rosacea comorbidities and treatment utilization over time.","display_name":"Changes in rosacea comorbidities and treatment utilization over time.","publication_year":2010,"publication_date":"2010-11-01","ids":{"openalex":"https://openalex.org/W13566433","mag":"13566433","pmid":"https://pubmed.ncbi.nlm.nih.gov/21061763"},"language":"en","primary_location":{"id":"pmid:21061763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21061763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Brad A Yentzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405269449","display_name":"Wake Forest University Health Sciences","ror":"https://ror.org/046r1r105","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]},{"id":"https://openalex.org/I47251452","display_name":"Wake Forest University","ror":"https://ror.org/0207ad724","country_code":"US","type":"education","lineage":["https://openalex.org/I47251452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad A Yentzer","raw_affiliation_strings":["Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1071, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1071, USA","institution_ids":["https://openalex.org/I4405269449","https://openalex.org/I47251452"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089682153","display_name":"Alan B. Fleischer","orcid":"https://orcid.org/0000-0001-8679-3352","observed_orcids":["https://orcid.org/0000-0001-8679-3352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alan B Fleischer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.733,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.69580271,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"9","issue":"11","first_page":"1402","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12116","display_name":"Dermatological diseases and infestations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rosacea","display_name":"rosacea","score":1.0},{"id":"https://openalex.org/keywords/comorbidity","display_name":"comorbidities","score":0.9509999752044678},{"id":"https://openalex.org/keywords/treatment-utilization","display_name":"treatment utilization","score":0.6430000066757202},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dermatologists","display_name":"dermatologists","score":0.6980000138282776},{"id":"https://openalex.org/keywords/antibiotic-resistance","display_name":"antibiotic resistance","score":0.699999988079071},{"id":"https://openalex.org/keywords/metronidazole","display_name":"metronidazole","score":0.8820000290870667},{"id":"https://openalex.org/keywords/tetracycline","display_name":"tetracycline","score":0.9980000257492065},{"id":"https://openalex.org/keywords/azelaic-acid","display_name":"azelaic acid","score":0.9980000257492065},{"id":"https://openalex.org/keywords/systemic-antibiotics","display_name":"systemic antibiotics","score":0.8690000176429749},{"id":"https://openalex.org/keywords/drug-use-trends","display_name":"drug use trends","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C2778081122","wikidata":"https://www.wikidata.org/wiki/Q831530","display_name":"Rosacea","level":3,"score":0.996711015701294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9181867837905884},{"id":"https://openalex.org/C2780285341","wikidata":"https://www.wikidata.org/wiki/Q413504","display_name":"Azelaic acid","level":2,"score":0.8800990581512451},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7300967574119568},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.6075278520584106},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5954376459121704},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.5457557439804077},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.4536234736442566},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1318674385547638},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012393","descriptor_name":"Rosacea","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012393","descriptor_name":"Rosacea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012871","descriptor_name":"Skin Diseases","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:21061763","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21061763","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4241403384","https://openalex.org/W2414290898","https://openalex.org/W4221055794","https://openalex.org/W2988309580","https://openalex.org/W2121067584","https://openalex.org/W2011296507","https://openalex.org/W122660915","https://openalex.org/W2402279207","https://openalex.org/W2800537629","https://openalex.org/W2421702196"],"abstract_inverted_index":{"BACKGROUND:":[0],"Rosacea":[1],"is":[2],"a":[3],"chronic":[4],"skin":[5,45],"condition":[6],"that":[7,142],"requires":[8],"lifelong":[9],"treatment.":[10],"Given":[11],"the":[12,35,40,50,81,99],"rise":[13],"in":[14,34],"antibiotic-resistant":[15],"bacteria,":[16],"many":[17],"physicians":[18],"are":[19,125],"re-evaluating":[20],"their":[21,118,127],"use":[22,128],"of":[23,28,37,67,83,120,129],"antibiotics":[24,131],"for":[25,108,113,132],"long-term":[26],"treatment":[27,36],"rosacea.":[29],"PURPOSE:":[30],"To":[31],"examine":[32],"trends":[33],"rosacea":[38,60,104,133],"and":[39,62,95,111,134],"comorbidities":[41],"associated":[42,88],"with":[43,89],"this":[44],"condition.":[46],"METHODS:":[47],"From":[48],"2002-2006,":[49],"National":[51],"Ambulatory":[52],"Medical":[53],"Care":[54],"Survey":[55],"queried":[56],"drug":[57],"mentions":[58],"at":[59,103],"visits":[61,79],"coexisting":[63],"diagnoses.":[64],"Prescribing":[65],"patterns":[66],"dermatologists":[68],"were":[69,87,98],"compared":[70],"to":[71,136,147],"other":[72],"physicians'":[73],"patterns.":[74],"RESULTS:":[75],"Ten":[76],"million":[77],"physician":[78],"had":[80],"diagnosis":[82],"rosacea;":[84],"74":[85],"percent":[86],"co-morbidities.":[90],"Metronidazole,":[91],"tetracyclines,":[92],"azelaic":[93,109,140],"acid":[94,110],"sodium":[96,114],"sulfacetamide":[97],"top":[100],"medications":[101],"mentioned":[102],"visits.":[105],"Prescriptions":[106],"increased":[107],"decreased":[112,117],"sulfacetamide.":[115],"Dermatologists":[116,124],"prescribing":[119],"systemic":[121,130],"medications.":[122],"CONCLUSION:":[123],"reducing":[126],"turning":[135],"therapies,":[137],"such":[138],"as":[139],"acid,":[141],"do":[143],"not":[144],"have":[145],"potential":[146],"induce":[148],"bacterial":[149],"resistance.":[150]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}